Sep 2026· Scientific digest of association of obstetricians and gynecologists of Ukraine· 0 citations· 28 references
TL;DR
The findings support transition to an organized, registry-based, and territorially balanced screening programme for cervical cancer in Kyiv in 2015-2024.
Abstract
Cervical cancer is largely preventable, yet its burden remains high where screening is predominantly opportunistic. A population-level assessment in a large city is essential for designing an organized earlydetection programme.
Materials and Methods. The study retrospectively analysed official statistics and population-based cancer registry data for Kyiv in 2015-2024. It assessed age-standardized incidence and mortality, the mortality-to-incidence ratio, temporal trends, age and stage distributions, five-year survival, histological and genotype profiles, and territorial variation across ten administrative districts.
Results. Kyiv had an age-standardized incidence of 15.6 and mortality of 6.4 per 100,000 women, with a mortality-to-incidence ratio of 0.41. These indicators were close to national values and three to four times higher than in countries with mature organized programmes. Screening coverage remained 28-32%. Early stages accounted for 71.2% of cases, while advanced stages represented 28.8%, and five-year survival was 58.3%. Survival showed a strong stage gradient, ranging from 98-99% for stage IA to 28-40% for stages III-IV. The integrated earlydetection organization index varied substantially between districts, with a coefficient of variation of 34.2%; 28.3% of examinations were performed outside the district of residence. Squamous cell carcinoma predominated histologically. High-risk human papillomavirus prevalence was 28.9%, with genotypes 16 and 18 predominating.
Conclusions. Kyiv has a high and territorially unequal cervical cancer burden, a substantial proportion of advanced disease, and insufficient survival. The findings support transition to an organized, registry-based, and territorially balanced screening programme.
Cervical cancer incidence increased in Cyprus between 2004 and 2017, with the sharpest rise seen among women aged 15 to 49 years, and survival improved over time, highlighting the need to strengthen HPV vaccination, screening, and timely access to care.
R. Pasumarthi, C. Kosharis, C. Demetriou et al.· European Journal of Public H...· 0 citations
Cervical cancer is a preventable malignancy whose mortality can expose inequities across the cancer control continuum. In Brazil, a middle-income country with universal health coverage but marked socioeconomic/geographic disparities, deaths from cervical cancer may indicate uneven access to prevention, screening, d...
Eleonora Balzan Fleck, Analissa Ferraz, Manuela Carneiro de Mattos et al.· JCO Global Oncology· 0 citations
IntroductionGlobally, cervical cancer is a public health problem, contributing to a substantial proportion of morbidity, disability, and mortality, particularly in low- and middle-income countries. Tracking the burden of the disease using the latest GBD 2023 estimates to provide updated national and subnational evidenc...
A. Atsbaha, H. Amare, Teshome Gensa Geta et al.· Cancer Control: Journal of t...· 0 citations
Abstract Background Cervical cancer remains a leading cause of morbidity and mortality among women in Uzbekistan, exceeding WHO elimination targets. Despite a school-based HPV vaccination program launched in 2019, screening coverage remains low, leading to delayed diagnoses; we examined cervical cancer trends in Tashke...
U. Mirzaev, J. Juraev, I. P. Sharipova et al.· JNCI Cancer Spectrum· 0 citations
Background Cancer incidence and mortality are rising in Africa, yet the distribution and determinants of cancer in high HIV-prevalence regions remain limited. We characterized cancer epidemiology, treatment, and survival among adults in western Kenya, where HIV prevalence ranges between 10.3% and 11.7%. Methods This re...
D. Mangale, H. Adhiambo, P. Adagi et al.· medRxiv· 0 citations
Cervical cancer remains among the leading causes of female mortality despite effective preventive strategies. This study aimed to compare cervical cancer incidence and mortality rates between Australia, a global benchmark in disease control, and Brazil, a country characterized by profound regional and socioeconomic...
Fernando Augusto Siuta dos Santos, Pedro Dytz Marin, Giulia Scain et al.· JCO Global Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.